Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles
Home
»
Gain Therapeutics Begins Promising Parkinson’s Phase 1b Study - Perspectives from Gain Therapeutics
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles
Related Posts
Gain Therapeutics Begins Promising Parkinson’s Phase 1b Study
Clinical Trial Vanguard
Sep 19, 2025
Gain Therapeutics Begins Promising Parkinson’s Phase 1b Study
Related Posts
Post navigation
Previous Post
Empowered Patient Podcast: Using AI in Drug Development to Protect Brain Enzyme Linked to Parkinson’s Disease Progression with Gene Mack Gain Therapeutics
Next Post
Gain extends trial of Parkinson’s treatment GT-02287 for 9 months
Latest Articles
Clear Filters
January 26, 2026
5 Investigational Therapies That Could Change the Parkinson’s Landscape
https://www.biospace.com/drug-development/5-investigational-therapies-that-could-change-the-parkinsons-landscape
Read More
January 13, 2026
Early trial data suggest GT-02287 may aid Parkinson’s symptoms
https://parkinsonsnewstoday.com/news/early-trial-data-suggest-gt-02287-aid-parkinsons-symptoms/
Read More
January 9, 2026
New data suggest enzyme modulator may slow Parkinson’s
https://longevity.technology/news/new-data-suggest-enzyme-modulator-may-slow-parkinsons/
Read More
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles